• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. Dec 15, 1996; 98(12): 2805–2812.
PMCID: PMC507747

Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation.

Abstract

Human beta cells can be maintained in serum-free culture at 6 mmol/liter glucose, with 80% cell recovery and preserved glucose-inducible functions after 1 wk. Between 0 and 10 mmol/liter, glucose dose-dependently increases the number of beta cells in active protein synthesis (15% at 0 mmol/liter glucose, 60% at 5 mmol/liter, and 82% at 10 mmol/liter), while lacking such an effect in islet non-beta cells (> 75% activated irrespective of glucose concentrations). As in rat beta cells, this intercellular difference in glucose sensitivity determines the dose-response curves during acute glucose stimulation of human beta cells. During 2-h incubations, human beta cells synthesize 7 fmol insulin/10(3) cells at 0 mmol/liter glucose, 20 fmol at 5 mmol/liter, and 31 fmol at 10 mmol/liter. Culture at higher (10 or 20 mmol/liter) glucose does not affect beta cell recovery but decreases by 50-85% the net effect of glucose upon insulin synthesis and release. These reduced responses to glucose are not caused by diminished cellular activities but are the consequence of a shift of beta cells to a state of sustained activation. The presence of more activated cells at low glucose eliminates glucose-dependent cell recruitment as a mechanism for adjusting beta cell responses to acute variations in glucose concentration. It leads to elevated basal biosynthetic (3-fold) and secretory (10-fold) activities, and, hence, to a 4-fold reduction in the beta cell insulin content and the amount of insulin released at maximal glucose stimulation. Prolonged exposure of human beta cells to high glucose can thus lead to a loss of their glucose regulation as a consequence of sustained cellular activation, without signs of glucose-induced toxicity or desensitization.

Full Text

The Full Text of this article is available as a PDF (368K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Yki-Järvinen H. Glucose toxicity. Endocr Rev. 1992 Aug;13(3):415–431. [PubMed]
  • DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992 Mar;15(3):318–368. [PubMed]
  • Leahy JL. Natural history of beta-cell dysfunction in NIDDM. Diabetes Care. 1990 Sep;13(9):992–1010. [PubMed]
  • Robertson RP, Olson LK, Zhang HJ. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes. 1994 Sep;43(9):1085–1089. [PubMed]
  • Robertson RP. Type II diabetes, glucose "non-sense," and islet desensitization. Diabetes. 1989 Dec;38(12):1501–1505. [PubMed]
  • Leahy JL, Bonner-Weir S, Weir GC. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass. Diabetes. 1984 Jul;33(7):667–673. [PubMed]
  • Leahy JL, Cooper HE, Deal DA, Weir GC. Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. J Clin Invest. 1986 Mar;77(3):908–915. [PMC free article] [PubMed]
  • Bonner-Weir S, Trent DF, Weir GC. Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest. 1983 Jun;71(6):1544–1553. [PMC free article] [PubMed]
  • Korsgren O, Jansson L, Sandler S, Andersson A. Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background. J Clin Invest. 1990 Dec;86(6):2161–2168. [PMC free article] [PubMed]
  • Jansson L, Eizirik DL, Pipeleers DG, Borg LA, Hellerström C, Andersson A. Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice. J Clin Invest. 1995 Aug;96(2):721–726. [PMC free article] [PubMed]
  • Bolaffi JL, Bruno L, Heldt A, Grodsky GM. Characteristics of desensitization of insulin secretion in fully in vitro systems. Endocrinology. 1988 May;122(5):1801–1809. [PubMed]
  • Davalli AM, Pontiroli AE, Socci C, Bertuzzi F, Fattor B, Braghi S, Di Carlo V, Pozza G. Human islets chronically exposed in vitro to different stimuli become unresponsive to the same stimuli given acutely: evidence supporting specific desensitization rather than beta-cell exhaustion. J Clin Endocrinol Metab. 1992 Apr;74(4):790–794. [PubMed]
  • Eizirik DL, Korbutt GS, Hellerström C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest. 1992 Oct;90(4):1263–1268. [PMC free article] [PubMed]
  • Purrello F, Vetri M, Gatta C, Gullo D, Vigneri R. Effects of high glucose on insulin secretion by isolated rat islets and purified beta-cells and possible role of glycosylation. Diabetes. 1989 Nov;38(11):1417–1422. [PubMed]
  • Leahy JL, Bumbalo LM, Chen C. Beta-cell hypersensitivity for glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized rats. Diabetologia. 1993 Dec;36(12):1238–1244. [PubMed]
  • Thibault C, Guettet C, Laury MC, N'Guyen JM, Tormo MA, Bailbé D, Portha B, Pénicaud L, Ktorza A. In vivo and in vitro increased pancreatic beta-cell sensitivity to glucose in normal rats submitted to a 48-h hyperglycaemic period. Diabetologia. 1993 Jul;36(7):589–595. [PubMed]
  • Hoenig M, MacGregor LC, Matschinsky FM. In vitro exhaustion of pancreatic beta-cells. Am J Physiol. 1986 May;250(5 Pt 1):E502–E511. [PubMed]
  • De Vos A, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D, Schuit F. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest. 1995 Nov;96(5):2489–2495. [PMC free article] [PubMed]
  • Pipeleers DG. Heterogeneity in pancreatic beta-cell population. Diabetes. 1992 Jul;41(7):777–781. [PubMed]
  • Pipeleers D, Kiekens R, Ling Z, Wilikens A, Schuit F. Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia. 1994 Sep;37 (Suppl 2):S57–S64. [PubMed]
  • Schuit FC, In't Veld PA, Pipeleers DG. Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3865–3869. [PMC free article] [PubMed]
  • Kiekens R, In 't Veld P, Mahler T, Schuit F, Van De Winkel M, Pipeleers D. Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. J Clin Invest. 1992 Jan;89(1):117–125. [PMC free article] [PubMed]
  • Warnock GL, Ellis DK, Cattral M, Untch D, Kneteman NM, Rajotte RV. Viable purified islets of Langerhans from collagenase-perfused human pancreas. Diabetes. 1989 Jan;38 (Suppl 1):136–139. [PubMed]
  • Pipeleers DG, in't Veld PA, Van de Winkel M, Maes E, Schuit FC, Gepts W. A new in vitro model for the study of pancreatic A and B cells. Endocrinology. 1985 Sep;117(3):806–816. [PubMed]
  • Pipeleers D, Van de Winkel M. Pancreatic B cells possess defense mechanisms against cell-specific toxicity. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5267–5271. [PMC free article] [PubMed]
  • Van Schravendijk CF, Kiekens R, Pipeleers DG. Pancreatic beta cell heterogeneity in glucose-induced insulin secretion. J Biol Chem. 1992 Oct 25;267(30):21344–21348. [PubMed]
  • Ling Z, Pipeleers DG. Preservation of glucose-responsive islet beta-cells during serum-free culture. Endocrinology. 1994 Jun;134(6):2614–2621. [PubMed]
  • Hellman B, Gylfe E, Bergsten P, Grapengiesser E, Lund PE, Berts A, Tengholm A, Pipeleers DG, Ling Z. Glucose induces oscillatory Ca2+ signalling and insulin release in human pancreatic beta cells. Diabetologia. 1994 Sep;37 (Suppl 2):S11–S20. [PubMed]
  • Hansen BC, Bodkin NL. Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. Am J Physiol. 1990 Sep;259(3 Pt 2):R612–R617. [PubMed]
  • Andersson A, Westman J, Hellerström C. Effects of glucose on the ultrastructure and insulin biosynthesis of isolated mouse pancreatic islets maintained in tissue culture. Diabetologia. 1974 Dec;10(6):743–753. [PubMed]
  • Liang Y, Najafi H, Smith RM, Zimmerman EC, Magnuson MA, Tal M, Matschinsky FM. Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture. Diabetes. 1992 Jul;41(7):792–806. [PubMed]
  • Purrello F, Buscema M, Rabuazzo AM, Caltabiano V, Forte F, Vinci C, Vetri M, Vigneri R. Glucose modulates glucose transporter affinity, glucokinase activity, and secretory response in rat pancreatic beta-cells. Diabetes. 1993 Jan;42(1):199–205. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...